PolyNovo


Polynovo is focused on improving patient outcomes and reimagining the standard of care through innovative products like NovoSorb® technology. The company is dedicated to enabling natural healing, expanding its global footprint, and providing solutions for complex wounds. It actively engages in clinical research, product development, and strategic partnerships to advance wound care and regenerative medicine.

Industries

medical-device

Nr. of Employees

medium (51-250)

PolyNovo

Port Melbourne, Victoria, Australia, Oceania


Products

Biodegradable temporizing dermal matrix (single‑use dermal scaffold)

A bilayer, single‑application synthetic dermal substitute comprising a temporary sealing membrane and an open‑cell biodegradable matrix designed to temporize deep wounds, support vascularized neodermis formation and permit staged definitive closure.


Services

Clinician education and training

Webinars, case studies, clinical application guidance and peer‑to‑peer education resources to support surgeon adoption and correct clinical use.

Investigator and clinical research support

Support for investigator‑initiated research and sponsored pivotal trials, including collaborations with government funders and enrollment support.

Expertise Areas

  • Dermal substitute development
  • Complex wound management and reconstruction
  • Biomaterials formulation (medical‑grade polyurethane)
  • Clinical trial management for medical devices
  • Show More (3)

Key Technologies

  • Biodegradable polyurethane scaffolds
  • Synthetic dermal substitute architecture (bilayer with sealing membrane)
  • Hydrolytic degradation characterization
  • Open‑cell matrix design with fenestrations
  • Show More (2)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.